1. Short title This Act may be cited as the Medicare Fair Drug Pricing Act of 2018 . 2. Requirement to determine lower covered part D drug prices for certain covered part D drugs (a) In general Section 1860D–11(i) of the Social Security Act ( 42 U.S.C. 1395w–111(i) ) is amended— (1) by striking (i) Noninterference.— In and inserting the following: (i) Noninterference (1) In general In ; (2) by inserting subject to paragraph (2), after part, ; and (3) by adding at the end the following new paragraph: (2) Exception for specified drugs (A) Requirement (i) In general Notwithstanding paragraph (1), the part D price for specified drugs shall be determined in accordance with the process described in subparagraph (B). (ii) Specified drugs For purposes of this paragraph, the term specified drug means a covered part D drug— (I) that is— (aa) a single source drug or biological; (bb) not a biological product licensed pursuant to an application under section 351(k) of the Public Health Service Act; and (cc) not both manufactured by more than two drug manufacturers and manufactured by at least one such manufacturer as a generic drug; or (II) that— (aa) is selected by the Secretary for purposes of this paragraph